Entourage Capex To Depreciation vs Ev To Sales Analysis

ENTG Stock

0.01 0.01 50.00%

Entourage Health financial indicator trend analysis is much more than just examining Entourage Health Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Entourage Health Corp is a good investment. Please check the relationship between Entourage Health Capex To Depreciation and its Ev To Sales accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entourage Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Capex To Depreciation vs Ev To Sales

Capex To Depreciation vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Entourage Health Corp Capex To Depreciation account and Ev To Sales. At this time, the significance of the direction appears to have no relationship.

The correlation between Entourage Health's Capex To Depreciation and Ev To Sales is 0.03. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Entourage Health Corp, assuming nothing else is changed. The correlation between historical values of Entourage Health's Capex To Depreciation and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Entourage Health Corp are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Capex To Depreciation i.e., Entourage Health's Capex To Depreciation and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.03

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Entourage Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Entourage Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entourage Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Enterprise Value is likely to climb to about 162.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 24.5 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	84.0M	92.9M	62.1M	58.8M
Cost Of Revenue	54.0M	60.8M	37.0M	33.9M

Total Operating Expenses Cost Of Revenue

Entourage Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Short Term Investments	Capital Stock	Other Liab
Total Assets		0.68	-0.04	0.59	0.8	0.07	0.83	-0.31	0.99	-0.55	0.72	0.59	0.34	0.72	0.84	0.89	0.39	0.26	0.99	0.93	0.23	0.46	0.67	-0.43	0.37	0.26
Other Current Liab	0.68		0.35	0.1	0.56	-0.29	0.76	-0.77	0.72	-0.71	0.29	0.45	0.49	0.46	0.75	0.76	0.55	0.49	0.62	0.58	-0.23	0.55	0.76	-0.61	0.54	-0.23
Total Current Liabilities	-0.04	0.35		-0.82	-0.27	-0.98	-0.16	-0.74	-0.06	-0.77	-0.31	0.41	0.89	-0.22	0.45	-0.1	0.85	0.89	-0.15	0.16	-0.98	0.81	0.67	-0.86	0.88	-0.74
Total Stockholder Equity	0.59	0.1	-0.82		0.67	0.85	0.62	0.42	0.6	0.34	0.59	0.1	-0.54	0.46	0.09	0.53	-0.48	-0.6	0.67	0.38	0.91	-0.42	-0.19	0.48	-0.52	0.73
Net Tangible Assets	0.8	0.56	-0.27	0.67		0.28	0.93	-0.28	0.83	-0.25	0.85	0.5	0.01	0.62	0.5	0.91	0.1	-0.04	0.81	0.64	0.41	0.18	0.46	-0.09	0.03	0.25
Retained Earnings	0.07	-0.29	-0.98	0.85	0.28		0.22	0.71	0.1	0.77	0.24	-0.31	-0.89	0.13	-0.43	0.09	-0.86	-0.91	0.17	-0.15	0.96	-0.83	-0.67	0.87	-0.89	0.71
Accounts Payable	0.83	0.76	-0.16	0.62	0.93	0.22		-0.43	0.87	-0.32	0.62	0.59	0.1	0.5	0.57	0.88	0.19	0.04	0.82	0.64	0.29	0.23	0.51	-0.18	0.11	0.22
Cash	-0.31	-0.77	-0.74	0.42	-0.28	0.71	-0.43		-0.32	0.79	-0.04	-0.52	-0.76	-0.08	-0.57	-0.42	-0.8	-0.77	-0.21	-0.33	0.68	-0.77	-0.82	0.78	-0.75	0.46
Non Current Assets Total	0.99	0.72	-0.06	0.6	0.83	0.1	0.87	-0.32		-0.53	0.72	0.58	0.3	0.71	0.82	0.91	0.36	0.22	0.99	0.9	0.25	0.42	0.65	-0.4	0.34	0.23
Other Assets	-0.55	-0.71	-0.77	0.34	-0.25	0.77	-0.32	0.79	-0.53		-0.26	-0.51	-0.92	-0.42	-0.89	-0.51	-0.92	-0.91	-0.47	-0.69	0.63	-0.94	-0.96	0.98	-0.96	0.44
Long Term Debt	0.72	0.29	-0.31	0.59	0.85	0.24	0.62	-0.04	0.72	-0.26		0.23	0.0	0.84	0.49	0.83	0.07	-0.02	0.74	0.66	0.45	0.18	0.41	-0.11	0.06	0.24
Net Receivables	0.59	0.45	0.41	0.1	0.5	-0.31	0.59	-0.52	0.58	-0.51	0.23		0.57	-0.06	0.61	0.38	0.57	0.43	0.54	0.63	-0.29	0.6	0.64	-0.51	0.5	-0.09
Common Stock Shares Outstanding	0.34	0.49	0.89	-0.54	0.01	-0.89	0.1	-0.76	0.3	-0.92	0.0	0.57		0.1	0.72	0.21	0.99	0.98	0.25	0.51	-0.8	0.98	0.88	-0.97	0.99	-0.43
Non Current Liabilities Total	0.72	0.46	-0.22	0.46	0.62	0.13	0.5	-0.08	0.71	-0.42	0.84	-0.06	0.1		0.6	0.83	0.15	0.13	0.73	0.67	0.36	0.24	0.45	-0.26	0.21	0.19
Inventory	0.84	0.75	0.45	0.09	0.5	-0.43	0.57	-0.57	0.82	-0.89	0.49	0.61	0.72	0.6		0.72	0.72	0.65	0.79	0.93	-0.27	0.77	0.89	-0.82	0.78	-0.19
Other Current Assets	0.89	0.76	-0.1	0.53	0.91	0.09	0.88	-0.42	0.91	-0.51	0.83	0.38	0.21	0.83	0.72		0.3	0.2	0.87	0.76	0.25	0.37	0.65	-0.35	0.28	0.13
Other Stockholder Equity	0.39	0.55	0.85	-0.48	0.1	-0.86	0.19	-0.8	0.36	-0.92	0.07	0.57	0.99	0.15	0.72	0.3		0.98	0.3	0.52	-0.76	0.99	0.91	-0.96	0.97	-0.4
Total Liab	0.26	0.49	0.89	-0.6	-0.04	-0.91	0.04	-0.77	0.22	-0.91	-0.02	0.43	0.98	0.13	0.65	0.2	0.98		0.16	0.41	-0.82	0.97	0.85	-0.95	0.97	-0.46
Net Invested Capital	0.99	0.62	-0.15	0.67	0.81	0.17	0.82	-0.21	0.99	-0.47	0.74	0.54	0.25	0.73	0.79	0.87	0.3	0.16		0.92	0.33	0.37	0.59	-0.33	0.28	0.34
Total Current Assets	0.93	0.58	0.16	0.38	0.64	-0.15	0.64	-0.33	0.9	-0.69	0.66	0.63	0.51	0.67	0.93	0.76	0.52	0.41	0.92		0.04	0.6	0.74	-0.6	0.56	0.12
Net Working Capital	0.23	-0.23	-0.98	0.91	0.41	0.96	0.29	0.68	0.25	0.63	0.45	-0.29	-0.8	0.36	-0.27	0.25	-0.76	-0.82	0.33	0.04		-0.7	-0.53	0.75	-0.77	0.76
Common Stock	0.46	0.55	0.81	-0.42	0.18	-0.83	0.23	-0.77	0.42	-0.94	0.18	0.6	0.98	0.24	0.77	0.37	0.99	0.97	0.37	0.6	-0.7		0.94	-0.96	0.97	-0.37
Property Plant Equipment	0.67	0.76	0.67	-0.19	0.46	-0.67	0.51	-0.82	0.65	-0.96	0.41	0.64	0.88	0.45	0.89	0.65	0.91	0.85	0.59	0.74	-0.53	0.94		-0.92	0.9	-0.35
Short Term Investments	-0.43	-0.61	-0.86	0.48	-0.09	0.87	-0.18	0.78	-0.4	0.98	-0.11	-0.51	-0.97	-0.26	-0.82	-0.35	-0.96	-0.95	-0.33	-0.6	0.75	-0.96	-0.92		-0.99	0.5
Capital Stock	0.37	0.54	0.88	-0.52	0.03	-0.89	0.11	-0.75	0.34	-0.96	0.06	0.5	0.99	0.21	0.78	0.28	0.97	0.97	0.28	0.56	-0.77	0.97	0.9	-0.99		-0.48
Other Liab	0.26	-0.23	-0.74	0.73	0.25	0.71	0.22	0.46	0.23	0.44	0.24	-0.09	-0.43	0.19	-0.19	0.13	-0.4	-0.46	0.34	0.12	0.76	-0.37	-0.35	0.5	-0.48

Click cells to compare fundamentals

Entourage Health Account Relationship Matchups

Entourage Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	209.8M	171.3M	144.2M	46.5M	31.4M	29.8M
Total Current Liabilities	29.1M	21.7M	116.4M	141.9M	172.3M	180.9M
Total Stockholder Equity	136.1M	74.1M	21.4M	(101.2M)	(147.3M)	(139.9M)
Net Tangible Assets	76.7M	98.9M	69.6M	21.4M	19.3M	18.3M
Retained Earnings	(27.7M)	(117.3M)	(196.2M)	(319.4M)	(365.5M)	(347.3M)
Accounts Payable	23.1M	7.6M	5.1M	2.7M	2.0M	1.9M
Cash	8.2M	22.3M	21.4M	9.1M	11.2M	13.5M
Non Current Assets Total	150.0M	104.5M	82.8M	6.4M	6.0M	5.7M
Net Receivables	6.1M	1.7M	7.6M	3.8M	2.9M	3.5M
Common Stock Shares Outstanding	186.5M	210.3M	304.0M	306.7M	308.4M	236.6M
Non Current Liabilities Total	44.6M	75.5M	6.4M	5.8M	6.4M	6.1M
Inventory	31.3M	30.7M	29.6M	14.8M	10.0M	19.6M
Other Current Assets	2.8M	10.8M	8.1M	707.2K	813.3K	772.6K
Total Liab	73.7M	97.2M	122.8M	147.7M	178.7M	101.5M
Net Invested Capital	180.2M	152.4M	123.8M	32.3M	13.6M	12.9M
Total Current Assets	59.8M	66.3M	61.4M	40.1M	25.4M	36.9M
Net Working Capital	30.6M	45.1M	(55.0M)	(101.8M)	(146.9M)	(139.6M)
Common Stock	79.7M	137.6M	163.2M	185.8M	213.7M	132.1M
Property Plant Equipment	41.0M	112.1M	100.0M	81.7M	94.0M	74.7M
Capital Stock	137.6M	163.2M	185.8M	186.1M	186.2M	172.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Entourage Stock Analysis

When running Entourage Health's price analysis, check to measure Entourage Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entourage Health is operating at the current time. Most of Entourage Health's value examination focuses on studying past and present price action to predict the probability of Entourage Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entourage Health's price. Additionally, you may evaluate how the addition of Entourage Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC